Pregnancy, baby, and childhood outcomes from using anti-seizure medication during pregnancy
Our findings corroborate the associated risks of valproate use and embryo malformations, support the use of lamotrigine and levetiracetam in pregnancy and raise concerns regarding gabapentinoid use in pregnancy.
Authors
- Tanja Mueller (ORCID: https://orcid.org/0000-0002-0418-4789)
- Amanj Baker Kurdi (ORCID: https://orcid.org/0000-0001-5036-1988)
- Stuart McTaggart (ORCID: https://orcid.org/0000-0001-6060-9019)
- Rachel Merrick (ORCID: https://orcid.org/0000-0003-2305-0898)
- Rachael Wood (ORCID: https://orcid.org/0000-0003-4453-623X)
- Leanne Hopkins (ORCID: https://orcid.org/0000-0002-7487-4363)
- Emily Moore (ORCID: https://orcid.org/0000-0002-9634-3299)
- Victoria Stark (ORCID: https://orcid.org/0009-0000-1244-4491)
- Marion Bennie (ORCID: https://orcid.org/0000-0002-4046-629X)
- Lynne Jarvis (ORCID: https://orcid.org/0009-0001-4706-199X)
- M. D. Millar (ORCID: https://orcid.org/0009-0002-6464-1483)
- Rute Vieira (ORCID: https://orcid.org/0000-0002-3599-7299)
Institutions
- University of Strathclyde (GB)
- University of Aberdeen (GB)
- Public Health Scotland (GB)
- Scotch Whisky Research Institute (GB)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1038/s43856-025-01285-9
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00